Skip to content

Comparison in Frequency of Hypotension Between Remimazolam and Propofol in Hip Surgery

Comparison in Frequency of Hypotension During Sedation of Propofol and Remimazolam in Spinal Anesthesia in Hip Surgery Patients: a Randomized Controlled Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05651399
Enrollment
78
Registered
2022-12-15
Start date
2022-12-26
Completion date
2023-06-14
Last updated
2025-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Spinal, Orthopedic Procedures, Propofol, Remimazolam, Sedatives

Brief summary

The purpose of this study is to compare the incidence of hypotension between remimazolam and propofol for intraoperative sedation in patients undergoing hip surgery with spinal anesthesia.

Interventions

DRUGRemimazolam

Patients receive remimazolam at a rate of 1 mg/kg/hr. When a patient's MOAA/S reaches 3 or less, the rate of remomazolam is maintained at a rate between 0.3 mg/kr/hr and 1.0 mg/kg/hr until the end of surgery.

DRUGPropofol

Patients are administered propofol with an effect-site concentration of 1.0 mcg/mL to 2.5 mcg/mL by target controlled infusion.

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* ASA physical status 1-3 * Patients scheduled for hip joint surgery under spinal anesthesia and sedation with propofol or remimzolam

Exclusion criteria

* Patients who refuse to participate in this study * Patients with uncontrolled high blood pressure, hyperthyroidism, dementia in the inability to communicate, or symptomatic coronary artery disease * Patients with an allergy to propofol, fentanyl, or bupivacaine * Patients contraindicated for spinal anesthesia, such as coagulopathy, severe aortic stenosis/mitral stenosis, and active infection on lumbar region * Patients judged to be inappropriate for this study

Design outcomes

Primary

MeasureTime frameDescription
Frequency of hypotension during surgery (1hour)up to 1 hour after initiation of drug infusionmean blood pressure less than 65mmHg

Secondary

MeasureTime frameDescription
Frequency of hypotension during surgeryThroughout the surgerymean blood pressure less than 65mmHg
Total administered phenylephrineThroughout the surgerytotal dose of phenylephrine administered during surgery
Fluid volumeThroughout the surgeryTotal amount of fluid infused during surgery
Number of hypotensive episodes in the post-anesthesia care unit after surgeryup to 1 hour after postanesthesia care unit entrymean blood pressure less than 65mmHg
Complications after surgeryup to 7 days after surgeryCardiovascular/neurological/respiratory complications, delirium, impaired renal function, or postoperative nausea and vomiting

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026